Krishna Institute of Medical Sciences (KIMS) reported a 23.3% increase in revenue, reaching INR965 crores in Q2 FY26. EBITDA stood at INR208 crores, while PAT reached INR72 crores. Average revenue per operating bed grew by 9.8% year-on-year. KIMS highlighted academic achievements, including winning the American College of Rheumatology Knowledge Bowl. The company aims to sustain a 27%-30% EBITDA margin in core clusters.
Financial Performance
Krishna Institute of Medical Sciences (KIMS) announced its Q2 FY26 results, showcasing significant growth in several key areas:
- Revenue: Total revenue reached INR965 crores, a 23.3% increase year-on-year.
- EBITDA: Reported at INR208 crores.
- PAT: Recorded at INR72 crores.
- EPS: Consolidated EPS for Q2 FY26 stood at INR1.67.
Operational Highlights
Key operational metrics for the quarter included:
- Average revenue per operating bed grew by 9.8% year-on-year.
- Inpatient (IP) volume grew by 15.3% year-on-year, reaching 64,288 patients.
- Outpatient (OP) volume increased by 25.1% year-on-year, totaling 5,92,725 patients.
Strategic Developments
KIMS continues to focus on expanding its reach and enhancing its service offerings:
- The company highlighted the introduction of a Medtronic major robotic guidance system at KIMS Kondapur, a first in Telangana and Andhra Pradesh for spine surgery.
- Asia’s first XR experience lab was launched at the Gachibowli unit.
- KIMS Manavata Hospitals, Nashik, launched a comprehensive cardiac unit.
- An exclusive IVF center opened in Banjara Hills attached to KIMS Sunshine Hospital.
Margin Outlook
KIMS is focused on maintaining strong EBITDA margins in its core clusters, particularly in Telangana and Andhra Pradesh, with a target of 25%-30%. Newer hospitals are expected to take approximately 12 months to ramp up and achieve profitability.
Source: BSE
